Stay updated on Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial

Sign up to get notified when there's something new on the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The record history now shows a new latest revision entry labeled v3.5.4. This replaces the previous v3.5.3 and indicates a minor update to the page’s revision history for this study.
    Difference
    0.1%
    Check dated 2026-05-14T23:11:24.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision: v3.5.3 is now displayed, replacing the previous v3.5.2. This indicates a new site release of ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2026-04-30T15:38:41.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    - Revision history now shows an added v3.5.2 entry and a removed v3.5.0 entry. - The page content and layout remain unchanged.
    Difference
    0.1%
    Check dated 2026-04-16T10:35:24.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    New record history entry for Study Status was added on 2026-03-11 (version 35, Revision: v3.5.0). The earlier revision 3.4.3 was removed on 2026-03-05.
    Difference
    0.3%
    Check dated 2026-03-18T17:47:16.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    New Study Status entry added to the record history. The page revision updated to v3.4.3 and the previous v3.4.2 revision was removed.
    Difference
    0.3%
    Check dated 2026-03-11T14:17:14.000Z thumbnail image
  9. Check
    114 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.4.2' was added to the history, and a government funding/operating-status notice was removed.
    Difference
    0.5%
    Check dated 2026-02-11T02:36:33.000Z thumbnail image

Stay in the know with updates to Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page.